Lonza cuts 2009 earning guidance and may reduce its workforce under “Project Bond” cost cutting plan after a Q3 characterized by an “accumulation of unexpected events”
Nokia, SAP and G&D are forming a company to provide anti-counterfeiting services which will draw on the firms’ respective expertise in mobile phones, supply chain technology and encryption.
Malvern Instruments and Kaiser Optical Systems have teamed up to meld Raman spectroscopy with particle characterisation in a unique combination that has application across the drug development and manufacturing process.
Increased focus on international markets, soaring demand for finished dosage forms and improved capacity usage helped India-based CMO Granules posting record revenues.
Portuguese CMO Hovione has bought an aseptic spray-drying line from US firm Acusphere and says that the demand for the technology is increasing as drug firms aim to boost bioavailability.
GEA Niro has begun offering contract spray-drying services for drug candidates and clinical trial supplies from its “Test Center” in Copenhagen, Denmark and wants the drug industry to know about the technique’s advantages.
Environmental and safety matters concern pharma “less than they should” when outsourcing to Asia, according to the CEO of Ash Stevens who believes there are long term benefits of using US-based companies.
Swedish CDMO Recipharm’s International Environmental Award helps emphasize the drug industry’s wider role in society, according to company chairman Lars Backsell.
Swiss healthcare services giant Lonza has withdrawn its offer for Canadian CMO Patheon, citing value considerations, rejection of the bid by JLL and the availability of alternatives.
Indian CRO Siro Clinpharma has ramped up clinical trial manufacturing capacity at its facility in Mumbai in response to growing demand from pharma and biotech firms.
Arch Pharmalabs is continuing its push to serve innovative pharma by adding simulated moving bed (SMB) technology, becoming the first in India to offer the offer the system for plant scale API manufacture.
SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.
Reaxa will set up an Indian subsidiary to manage supply chain, commercial scale production and application development for its growing number of customers in the country.
NextPharma Technologies has added clinical trial services to its US offering to meet what product development services MD Sean Marett described as growing demand for single source outsourcing solutions.
We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
US firm 3M Drug Delivery Systems has set its sights on the Asia-Pacific region, with a new lab in Singapore which, it says, will help it better serve both local and international markets.
Pharmatek has enhanced its preclinical and early stage clinical GMP supply capabilities by installing Capsugel’s Xcelodose system, becoming the first CDMO on the West Coast, US to have the equipment.
UK pharmaceutical test media supplier Cherwell Laboratories says its receipt of BSI ISO 9001:2008 accreditation demonstrates its commitment to quality.
Rexam has merged its Pharma, Primary Packaging and Prescription units into a new Healthcare division to keep pace with the increasingly globalized drug manufacturing industry's regulatory demands.
Buoyed by an increase in repeat business and deals with large pharma companies Ash Stevens has begun a $6m (€4.1m) expansion of its API manufacturing facility, with further phases planned to occur over the next six years.
Caraco Pharmaceutical Laboratories has entered into a consent decree with the FDA which details a series of measures that must be fulfilled to allow the company to resume manufacturing.
ATMI has launched a powder transfer bag, for substances such as APIs and excipients, which it claims has three times the shelf life of alternatives, increases process efficiency and improves safety.
Dutch contract delivery services firm OctoPlus says it will cut 35 jobs as part of ongoing efforts to boost efficiency, improve competitiveness and broaden its client base and revenue streams.
Fierce competition from India and China means it is unlikely that CROs and CMOs in CEE can generate sustainable growth, according to a report that believes the service model must be a “stepping stone” to creating innovative R&D businesses.
Canadian biologics CMO BioVectra has been contracted to make trial supplies of the candidate cancer treatment Prolanta by US biopharmaceutical firm Oncolix.
Having filed for bankruptcy in December Introgen Therapeutics has sold its assets, including management and technical team, to Vivante, a company that formed last week as a contract manufacturing organisation (CMO).
West has opened its first manufacturing facility in China to meet rising demand but the process has taken since 2006 and been “very tedious”, its president of West Asia Pacific told Outsourcing-Pharma.
UK based contract API maker Aesica Pharmaceuticals has been granted a Home Office license to make controlled substances at its facility in Cramlington, Northumberland.
The Chao Center for Industrial Pharmacy and contract manufacturing is to donate $360,000 worth of the antibiotic Seromycin to the Global Health Committee’s fight against multidrug rtesistant tuberculosis (MDR-TB) in Cambodia and Ethiopia.
Portugese CMO Hovione has had its captisol manufacturing contract extended until 2019 in a new agreement with US specialty drugmaker CyDex Pharmaceuticals.
US CMO Florida Biologix (FB) says its new contract with America Stem Cell (ASC) shows that demand for trial-phase biologics manufacturing is starting to recover.
Dalton Pharma Services has rolled out a new formulation development service that completes the firm’s contract drug manufacturing offering according to CEO Peter Pekos.
UK CMO SCM Pharma says its new commercial supply service, due to be officially launched at next month’s ICSE conference in Madrid, has already won two long-term manufacturing contracts.
Shanghai The First Biochemical & Pharmaceutical Company has installed Praxair China’s NCOOL cryogenic heat exchanger, becoming the first company to sign this sort of liquid nitrogen supply contract.
Novasep’s API manufacturing facility in Le Mans, France has been certified under the potent compound safety programme run by occupational health and safety specialist SafeBridge Consultants.
Revenues from Pall’s biopharmaceuticals division grew in fiscal 2009, excluding foreign currency changes, with the company benefiting from the “thriving market” for vaccines and expanding adoption of single-use systems.
Patheon has posted “disappointing” Q3 results, with manufacturing difficulties in Puerto Rico, a slowdown in demand for development services and reduced client demand for some products impacting on revenues.
Angel Biotechnology has inked a deal to manufacture the CTX stem cell line, which can now be frozen and thawed when needed, at its dedicated cell-based therapies plant that is equipped and licensed for the task.
Dishman is pushing ahead with its international expansion, increasing efforts to win contracts in the US and Japan and nearing completion of a facility Shanghai, China, which is the first it has built outside of India.
Struggling biotech Targeted Genetics (TG) has sold certain patents and AAV manufacturing technology to fellow US group Genzyme in a $7m deal that “shifts the firm out of crisis mode,” according to CEO Susan Robinson.
With Lonza and JLL competing over Patheon Outsourcing-Pharma looks at what the CMO offers to a prospective buyer, analysing its global manufacturing capacity and backlog using interactive maps and graphs.
UK API maker and contract manufacturing organization (CMO) Aesica Pharmaceutical has landed a multi-year deal to produce and package drugs on behalf of Amdipharm.
